Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $221,813 - $259,867
-913 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $1.22 Million - $1.41 Million
-4,602 Reduced 83.45%
913 $259,000
Q2 2020

Aug 13, 2020

BUY
$258.66 - $342.55 $152,609 - $202,104
590 Added 11.98%
5,515 $1.48 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $1.65 Million - $2.1 Million
-6,152 Reduced 55.54%
4,925 $1.56 Million
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $25,086 - $34,663
-114 Reduced 1.02%
11,077 $3.29 Million
Q3 2019

Nov 13, 2019

BUY
$217.44 - $243.88 $1.1 Million - $1.24 Million
5,066 Added 82.71%
11,191 $2.61 Million
Q2 2019

Aug 13, 2019

SELL
$219.29 - $241.72 $22,586 - $24,897
-103 Reduced 1.65%
6,125 $1.43 Million
Q1 2019

May 13, 2019

BUY
$216.71 - $338.96 $924,484 - $1.45 Million
4,266 Added 217.43%
6,228 $1.47 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $56,257 - $71,255
202 Added 11.48%
1,962 $590,000
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $2,348 - $3,070
-8 Reduced 0.45%
1,760 $622,000
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $24,611 - $27,566
-80 Reduced 4.33%
1,768 $563,000
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $519,565 - $609,267
1,848
1,848 $579,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Strategic Global Advisors, LLC Portfolio

Follow Strategic Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.